136 related articles for article (PubMed ID: 27694835)
1. The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway.
Mai H; Xu X; Mei G; Hong T; Huang J; Wang T; Yan Z; Li Y; Liang Y; Li L; Jin S; You W; Ma Y; Chen L; Ye Q
Oncogenesis; 2016 Oct; 5(10):e260. PubMed ID: 27694835
[TBL] [Abstract][Full Text] [Related]
2. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
3. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
4. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
Feng Y; Li L; Zhang X; Zhang Y; Liang Y; Lv J; Fan Z; Guo J; Hong T; Ji B; Ji Q; Mei G; Ding L; Zhang S; Xu X; Ye Q
Cancer Sci; 2015 Oct; 106(10):1313-22. PubMed ID: 26211905
[TBL] [Abstract][Full Text] [Related]
6. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition.
Xu X; Jiang C; Wang S; Tai Y; Wang T; Kang L; Fan Z; Li S; Li L; Fu J; Liu J; Ji Q; Wang X; Wei L; Ye Q
IUBMB Life; 2013 Oct; 65(10):873-82. PubMed ID: 24038948
[TBL] [Abstract][Full Text] [Related]
7. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis.
Okada S; Irié T; Tanaka J; Yasuhara R; Yamamoto G; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
J Oral Pathol Med; 2015 Feb; 44(2):115-25. PubMed ID: 25060351
[TBL] [Abstract][Full Text] [Related]
8. HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway.
Pan J; Qin Y; Zhang M
Biomed Pharmacother; 2016 Feb; 77():176-81. PubMed ID: 26796282
[TBL] [Abstract][Full Text] [Related]
9. The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.
Wang D; Wang L; Zhou Y; Zhao X; Xiong H
Tumour Biol; 2016 May; 37(5):5897-903. PubMed ID: 26590606
[TBL] [Abstract][Full Text] [Related]
10. A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.
Li P; Cao S; Huang Y; Zhang Y; Liu J; Cai X; Zhou L; Li J; Jiang Z; Ding L; Zheng Z; Li S; Ye Q
Cell Death Discov; 2021 Jul; 7(1):198. PubMed ID: 34326318
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
Wang Y; Li D; Liu Y; Tian S; Chen X
Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics.
Bugide S; David D; Nair A; Kannan N; Samanthapudi VS; Prabhakar J; Manavathi B
Oncogene; 2015 Aug; 34(35):4601-12. PubMed ID: 25486428
[TBL] [Abstract][Full Text] [Related]
13. Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancer.
Khumukcham SS; Manavathi B
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188576. PubMed ID: 34090932
[TBL] [Abstract][Full Text] [Related]
14. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
15. The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation.
Lin TC; Su CY; Wu PY; Lai TC; Pan WA; Jan YH; Chang YC; Yeh CT; Chen CL; Ger LP; Chang HT; Yang CJ; Huang MS; Liu YP; Lin YF; Shyy JY; Tsai MD; Hsiao M
Elife; 2016 Mar; 5():. PubMed ID: 26984280
[TBL] [Abstract][Full Text] [Related]
16. Expression of HPIP in epithelial ovarian carcinoma: a clinicopathological study.
Wang Y; Meng F; Liu Y; Chen X
Onco Targets Ther; 2017; 10():95-100. PubMed ID: 28053543
[TBL] [Abstract][Full Text] [Related]
17. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
18. ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway.
Zhu X; Xu A; Zhang Y; Huo N; Cong R; Ma L; Chu Z; Tang Z; Kang X; Xian S; Xu X
Onco Targets Ther; 2020; 13():10515-10523. PubMed ID: 33116630
[TBL] [Abstract][Full Text] [Related]
19. HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
Chen B; Zhao J; Zhang S; Zhang Y; Huang Z
Oncol Rep; 2016 Dec; 36(6):3664-3672. PubMed ID: 27748944
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of HPIP and the associated prognosis in cervical cancer.
Meng F; Liu H; Liu S; Ma R
Oncotarget; 2017 Sep; 8(41):70262-70270. PubMed ID: 29050277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
